Representation of multimorbidity and frailty in the development and validation of kidney failure prognostic prediction models: a systematic review.

Autor: Walker H; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland. heather.walker.2@glasgow.ac.uk., Day S; Renal Department, NHS Grampian, Aberdeen, Scotland., Grant CH; Population Health and Genomics, School of Medicine, University of Dundee, Dundee, Scotland., Jones C; General Practice and Primary Care, School of Health and Wellbeing, University of Glasgow, Glasgow, Scotland., Ker R; Renal and Transplant Unit, Queen Elizabeth University Hospital, Glasgow, Scotland., Sullivan MK; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland.; Renal and Transplant Unit, Queen Elizabeth University Hospital, Glasgow, Scotland., Jani BD; General Practice and Primary Care, School of Health and Wellbeing, University of Glasgow, Glasgow, Scotland., Gallacher K; General Practice and Primary Care, School of Health and Wellbeing, University of Glasgow, Glasgow, Scotland., Mark PB; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland.; Renal and Transplant Unit, Queen Elizabeth University Hospital, Glasgow, Scotland.
Jazyk: angličtina
Zdroj: BMC medicine [BMC Med] 2024 Oct 11; Vol. 22 (1), pp. 452. Date of Electronic Publication: 2024 Oct 11.
DOI: 10.1186/s12916-024-03649-9
Abstrakt: Background: Prognostic models that identify individuals with chronic kidney disease (CKD) at greatest risk of developing kidney failure help clinicians to make decisions and deliver precision medicine. It is recognised that people with CKD usually have multiple long-term health conditions (multimorbidity) and often experience frailty. We undertook a systematic review to evaluate the representation and consideration of multimorbidity and frailty within CKD cohorts used to develop and/or validate prognostic models assessing the risk of kidney failure.
Methods: We identified studies that described derivation, validation or update of kidney failure prognostic models in MEDLINE, CINAHL Plus and the Cochrane Library-CENTRAL. The primary outcome was representation of multimorbidity or frailty. The secondary outcome was predictive accuracy of identified models in relation to presence of multimorbidity or frailty.
Results: Ninety-seven studies reporting 121 different kidney failure prognostic models were identified. Two studies reported prevalence of multimorbidity and a single study reported prevalence of frailty. The rates of specific comorbidities were reported in a greater proportion of studies: 67.0% reported baseline data on diabetes, 54.6% reported hypertension and 39.2% reported cardiovascular disease. No studies included frailty in model development, and only one study considered multimorbidity as a predictor variable. No studies assessed model performance in populations in relation to multimorbidity. A single study assessed associations between frailty and the risks of kidney failure and death.
Conclusions: There is a paucity of kidney failure risk prediction models that consider the impact of multimorbidity and/or frailty, resulting in a lack of clear evidence-based practice for multimorbid or frail individuals. These knowledge gaps should be explored to help clinicians know whether these models can be used for CKD patients who experience multimorbidity and/or frailty.
Systematic Review Registration: This review has been registered on PROSPERO (CRD42022347295).
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje